Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

Vox Sanguinis

Volumn 78, Issue 4, 2000, Pages 209-216

  Knutson, Folke ^a   Alfonso, Ryan ^b   Dupuis, Kent ^b   Mayaudon, Véronique ^c   Lin, Lily ^b   Corash, Laurence ^b   Högman, Claes F ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b CERUS CORPORATION   (United States)

^c Baxter R and D Europe   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN; THROMBOCYTE CONCENTRATE;

ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; BACTERIUM CONTAMINATION; CONTROLLED STUDY; ENTEROBACTER AEROGENES; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHOTOCHEMISTRY; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS; ULTRAVIOLET IRRADIATION; VIRUS INACTIVATION;

EID: 0033909925     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031183     Document Type: Article

References (29)

1. Busch MP: HIV and blood transfusion. Focus on seroconversion. Vox Sang 1994;67S3.1:13-18.
2. Blajchman MA, Ali AM, Richardson HL: Bacterial contamination of cellular blood components. Vox Sung 1994;67S3:25-33.
3. Chiu EKW, Yuen KY, Lie AKW, Lie R, Liang R, Lau YL, Lee ACW, Kwong YL, Wong S, Ng MH, Chan TK: A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion 1994; 34:950-954.
4. Högman CF: Adverse effects: Bacterial contaimination (including shelf life). A brief review of bacterial contamination of blood components. Vox Sang 1996;70S3:78-82.
5. Alter HJ, Creagan RP, Morel PA, Wiesenhahn GP, Dorman BP, Corash L, Smith GC, Popper E, Eichberg JW: Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus. Lancet 1988;ii: 1446-1450.
6. Kanne D, Straub K, Rapoport H, Hearst JE: Psoralen-DNA photoreaction: Characterization of the monoaddition products from 8-methoxypsoralen and 4, 5′, 8-trimethoxypsoralen. Biochemistry 1982;21:861-871.
7. Lin L, Wiesehahn GP, Morel PA, Corash L: Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood 1989;74: 517-525.
8. Corash L, Lin L, Wiesehahn G: Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood Cells 1992;18:57-74.
9. Lin L, Londe H, Hanson VC, Wiesehahn G, Isaacs S, Cimino G, Corash L: Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates. Blood 1993;82:292-297.
10. Lin L, Londe H, Janda JM, Hanson CV, Corash L: Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 1994;83:2698-2706.
11. Billard V, Gambus PL, Barr J, Minto CF, Corash L, Tessman JW, Stickney JL, Shafer SL: The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans. Br J Clin Pharmacol 1995;40:347-360.
12. Wollowitz S, Cook D, Londe H, Hanson CV, Lin L, Isaacs S, Corash L: Inactivation of pathogenic viruses in human platelet concentrates with a novel psoralen. Vox Sang 1994; 67(suppl 2): 162.
13. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reamses AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S. Corash L: Photochemical inactivation of viruses and bacteria in human platelet concentrates using a novel psoralen and long wavelength ultraviolet light. Transfusion 1997;37:423-435.
14. Högman CF, Eriksson L, Hedlund K, Wallvik J: The bottom and top system: A new technique for blood component preparation and storage. Vox Sang 1988;55:211-217.
15. Högman CF, Eriksson L, Kristensen J: Leukocyte depleted platelets prepared from pooled huffy coat. Post-transfusion increment and 'in vitro bleeding time' using the Thrombostat 4000/2. Transfus Sci 1993;14:35-39.
16. Holme S, Murphy S: Quantitative measurements of platelet shape by light transmission studies; application to storage of platelets for transfusion. J Lab Clin Med 1978;92:53-64.
17. Holme S, Heaton WA, Courtright M: Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987;66:233-238.
18. Gong J, Högman CF, Lundholm M, Gustafsson I: Novel atuomated microbial screening of platelet concentrates. APMIS 1994; 102:72-78.
19. Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497.
20. Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, Stromberg R: In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994;8:29-36.
21. Eriksson L, Kristensen J, Olsson K, Bring J, Högman CF: Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coats and apheresis. Vox Sang 1996;70:69-75.
22. Yomtovian R: Bacteriologie surveillance of platelets. Workshop on Microbial Contamination of Blood Components, National Heart. Lung, and Blood Institute, NIH, Bethesda, September 1995.
23. Grass JA, Hei DJ, Metchette K. Cimino GD, Wiesehahn GP, Corash L, Lin L: Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998;91:2180-2188.
24. Hei DJ, Grass J, Lin L, Corash L, Cimino G: Elimination of cytokine production in stored platelet concentrates by photochemical treatment with psoralen plus UVA. Transfusion 1999;39:239-248.
25. Grass JA, Wafa T, Reames A, Wages D, Corash L, Ferara LM, Lin L: Prevention of transfusion associated graft vs. host disease TA-GVHD) by photochemical treatment. Blood 1999;93: 3140-3147.
26. Högman CF, Gong J, Eriksson L, Hamhraeus A, Johansson CS: White cells protect donor blood against bacterial contamination. Transfusion 191;31:620-626.
27. Dikeman R, Damonte P, Grass J, Lin L: Photochemical inactivation of pathogenic bacteria in human platelet concentrates using a novel psoralen (abstract L-21). 96th Annual Meeting of the American Society for Micorbiology, New Orleans 1996.
28. Blajchman MA, Lee DH: The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfus Med Rev 1997; 11:95-105.
29. Slichter SJ, Corash L, Grabowski M. Leblanc R, Sedgwick J, Townsend-McCall D, Davis K, Behrman B, Rheinschmidt M, Metzel P, Lin L, Buchholz, DH: Viability and hemostatic function of photochemically treated (PCT) platelets in thrombocytopenic patients. Blood, in press.